CD44 is considered as one of the best cancer stem cell markers. A significant correlation of CD44 mRNA expression as well as CD44 immunohistochemical score with local tumor control after radiotherapy was shown in a hypothesis-driven approach. The gene discussed is CD44; the disease is neoplasm.